Biography
Dr. Maron is the C.F. Rehnborg Professor of Medicine at Stanford University School of Medicine. He received his undergraduate degree from Stanford and his medical degree from the University of Southern California. He trained in internal medicine at UCLA. He returned to Stanford where he was a Robert Wood Johnson Clinical Scholar, a preventive cardiology fellow at the Stanford Prevention Research Center, and remained at Stanford to complete a cardiology fellowship. After a brief stint in private practice in Santa Monica, he joined the faculty at Vanderbilt University School of Medicine as Assistant Professor and Director of Preventive Cardiology in 1993, and rose through the ranks to Professor. In 2014 he returned to Stanford where he serves as Chief of SPRC.
Dr. Maron sees patients in the Preventive Cardiology Clinic. His research interests include primary and secondary prevention of coronary artery disease. As a fellow at SPRC, he was introduced to clinical research as a member of the team that conducted the Stanford Coronary Risk Intervention Project. He applied lessons learned from that experience to the design of the landmark COURAGE trial, for which he served as the chairman of the optimal medical therapy committee. He went on to be principal investigator and co-chair of the ISCHEMIA trial, an NIH-funded study comparing the effectiveness of two initial management strategies – invasive (optimal medical therapy plus cardiac catheterization and revascularization with stents or bypass surgery) versus conservative (optimal medical therapy alone) – in approximately 5,000 patients with stable coronary artery disease and at least moderate ischemia on a stress test. There was no overall statistical difference in major clinical endpoints in ISCHEMIA, but patients with angina had better symptom relief with invasive management. COURAGE and ISCHEMIA have had a major impact on the management of stable coronary disease around the world, with both trials emphasizing the importance of lifestyle and appropriate medications to control risk factors and prevent heart attacks and death.
Dr. Maron’s current research involves early detection of subclinical coronary disease in people without a diagnosis of heart disease. One method that he is investigating is using an artificial intelligence algorithm that he helped develop to measure calcified plaque in coronary arteries from a chest CT scan done for other purposes. His team has shown that detection and notification of patients and their clinicians about the presence of coronary calcium dramatically increases the use of statins as recommended by guidelines. Another method he is investigating is the use of noninvasive coronary CT angiograms to guide the management of patients at increased risk of heart disease as compared with strictly relying on risk factors. With these projects he hopes to transform the methods commonly used to prevent heart attacks.
Dr. Maron is president-elect of the American Society for Preventive Cardiology.
Dr. Maron sees patients in the Preventive Cardiology Clinic. His research interests include primary and secondary prevention of coronary artery disease. As a fellow at SPRC, he was introduced to clinical research as a member of the team that conducted the Stanford Coronary Risk Intervention Project. He applied lessons learned from that experience to the design of the landmark COURAGE trial, for which he served as the chairman of the optimal medical therapy committee. He went on to be principal investigator and co-chair of the ISCHEMIA trial, an NIH-funded study comparing the effectiveness of two initial management strategies – invasive (optimal medical therapy plus cardiac catheterization and revascularization with stents or bypass surgery) versus conservative (optimal medical therapy alone) – in approximately 5,000 patients with stable coronary artery disease and at least moderate ischemia on a stress test. There was no overall statistical difference in major clinical endpoints in ISCHEMIA, but patients with angina had better symptom relief with invasive management. COURAGE and ISCHEMIA have had a major impact on the management of stable coronary disease around the world, with both trials emphasizing the importance of lifestyle and appropriate medications to control risk factors and prevent heart attacks and death.
Dr. Maron’s current research involves early detection of subclinical coronary disease in people without a diagnosis of heart disease. One method that he is investigating is using an artificial intelligence algorithm that he helped develop to measure calcified plaque in coronary arteries from a chest CT scan done for other purposes. His team has shown that detection and notification of patients and their clinicians about the presence of coronary calcium dramatically increases the use of statins as recommended by guidelines. Another method he is investigating is the use of noninvasive coronary CT angiograms to guide the management of patients at increased risk of heart disease as compared with strictly relying on risk factors. With these projects he hopes to transform the methods commonly used to prevent heart attacks.
Dr. Maron is president-elect of the American Society for Preventive Cardiology.
View Full Biography
Professional Summary
Education & Certifications
- Medical Education: University of Southern California Keck School of Medicine (1981) CA
- Fellowship: Stanford University Cardiovascular Medicine Fellowship (1991) CA
- Residency: Stanford University Internal Medicine Residency (1986) CA
-
- Residency: UCLA Medical Center Internal Medicine (1984) CA
- Board Certification: American Board of Internal Medicine, Internal Medicine (1984)
- Board Certification: American Board of Internal Medicine, Cardiovascular Disease (1991)
Publications
-
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations
Davidson, M. H., Maki, K. C., Pearson, T. A., Pasternak, R. C., Deedwania, P. C., McKenney, J. M., … Ballantyne, C. M. (2005). Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. AMERICAN JOURNAL OF CARDIOLOGY, 96(4), 556–563. -
SATURATED FAT INTAKE AND INSULIN RESISTANCE IN MEN WITH CORONARY-ARTERY DISEASE
Maron, D. J., Fair, J. M., & Haskell, W. L. (1991). SATURATED FAT INTAKE AND INSULIN RESISTANCE IN MEN WITH CORONARY-ARTERY DISEASE. CIRCULATION, 84(5), 2020–2027. -
DEPRESSIVE SYMPTOMS AND SUBSTANCE USE AMONG ADOLESCENT BINGE EATERS AND PURGERS - A DEFINED POPULATION STUDY
Killen, J. D., Taylor, C. B., Telch, M. J., Robinson, T. N., Maron, D. J., & Saylor, K. E. (1987). DEPRESSIVE SYMPTOMS AND SUBSTANCE USE AMONG ADOLESCENT BINGE EATERS AND PURGERS - A DEFINED POPULATION STUDY. AMERICAN JOURNAL OF PUBLIC HEALTH, 77(12), 1539–41. -
-
Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
Maron, D. J., Spertus, J. A., Mancini, G. B. J., Hartigan, P. M., Sedlis, S. P., Bates, E. R., … Boden, W. E. (2009). Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial. AMERICAN JOURNAL OF CARDIOLOGY, 104(8), 1055–1062. -
Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
Maron, D. J., Boden, W. E., Spertus, J. A., Hartigan, P. M., Mancini, G. B. J., Sedlis, S. P., … O'Rourke, R. A. (2011). Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(2), 131–137. -
Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy Observations From the COURAGE Trial
Mancini, G. B. J., Hartigan, P. M., Bates, E. R., Sedlis, S. P., Maron, D. J., Spertus, J. A., … Boden, W. E. (2011). Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy Observations From the COURAGE Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 4(6), 545–552. -
Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists
Maron, D. J., Stone, G. W., Berman, D. S., Mancini, G. B. J., Scott, T. A., Byrne, D. W., … Spertus, J. A. (2011). Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists. AMERICAN HEART JOURNAL, 162(6), 1034–U124. -
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention
Shaw, L. J., Weintraub, W. S., Maron, D. J., Hartigan, P. M., Hachamovitch, R., Min, J. K., … Berman, D. S. (2012). Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. AMERICAN HEART JOURNAL, 164(2), 243–250. -
Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial
Spertus, J. A., Maron, D. J., Cohen, D. J., Kolm, P., Hartigan, P., Weintraub, W. S., … Mancini, G. B. J. (2013). Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 6(4), 409–418. -
Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Acharjee, S., Boden, W. E., Hartigan, P. M., Teo, K. K., Maron, D. J., Sedlis, S. P., … Weintraub, W. S. (2013). Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(20), 1826–1833. -
As REGARDS treatment goal attainment compared with COURAGE: the perfect should not be the enemy of the good.
Maron, D. J., & Boden, W. E. (2014). As REGARDS treatment goal attainment compared with COURAGE: the perfect should not be the enemy of the good. Journal of the American College of Cardiology, 63(16), 1634–35. -
Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs.
Maron, D. J., & Hlatky, M. A. (2014). Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs. American Heart Journal, 168(1), 4–5. -
Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging.
Shaw, L. J., Berman, D. S., Picard, M. H., Friedrich, M. G., Kwong, R. Y., Stone, G. W., … Douglas, P. S. (2014). Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC. Cardiovascular Imaging, 7(6), 593–604. -
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III).
Doran, B., Guo, Y., Xu, J., Weintraub, H., Mora, S., Maron, D. J., & Bangalore, S. (2014). Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III). Circulation, 130(7), 546–53. -
Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)".
Doran, B., Guo, Y., Xu, J., Weintraub, H., Mora, S., Maron, D. J., & Bangalore, S. (2015). Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)". Circulation, 131(19). -
Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
Bradley, S. M., Chan, P. S., Hartigan, P. M., Nallamothu, B. K., Weintraub, W. S., Sedlis, S. P., … Spertus, J. A. (2015). Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 116(2), 167–73. -
Machine learning for risk prediction of acute coronary syndrome.
Vanhouten, J. P., Starmer, J. M., Lorenzi, N. M., Maron, D. J., & Lasko, T. A. (2014). Machine learning for risk prediction of acute coronary syndrome. AMIA ... Annual Symposium Proceedings / AMIA Symposium. AMIA Symposium, 2014, 1940–49. -
Primary Prevention of Heart Failure in Older Adults.
Maron, D. J., & Hunt, S. A. (2015). Primary Prevention of Heart Failure in Older Adults. JACC. Heart Failure, 3(7), 529–30. -
Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia The Case for Community Equipoise
Stone, G. W., Hochman, J. S., Williams, D. O., Boden, W. E., Ferguson, T. B., Harrington, R. A., & Maron, D. J. (2016). Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia The Case for Community Equipoise. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(1), 81–99. -
Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool.
Collins, S. P., Jenkins, C. A., Harrell, F. E., Liu, D., Miller, K. F., Lindsell, C. J., … Storrow, A. B. (2015). Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool. JACC. Heart Failure, 3(10), 737–47. -
Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial)
Padala, S. K., Sidhu, M. S., Hartigan, P. M., Maron, D. J., Teo, K. K., Sperms, J. A., … Boden, W. E. (2015). Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial). AMERICAN JOURNAL OF CARDIOLOGY, 116(10), 1509–15. -
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Sedlis, S. P., Hartigan, P. M., Teo, K. K., Maron, D. J., Spertus, J. A., Mancini, G. B. J., … Boden, W. E. (2015). Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. NEW ENGLAND JOURNAL OF MEDICINE, 373(20), 1937–46. -
Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
Cheng-Torres, K. A., Desai, K. P., Sidhu, M. S., Maron, D. J., & Boden, W. E. (2016). Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial? Future Cardiology, 12(1), 35–44. -
Treatment of Patients With Stable Ischemic Heart Disease--Reply.
Bangalore, S., Maron, D. J., & Hochman, J. S. (2016). Treatment of Patients With Stable Ischemic Heart Disease--Reply. JAMA, 315(17), 1905–6. -
Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions.
Hong, J., Maron, D. J., Shirai, T., & Weyand, C. M. (2015). Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions. International Journal of Clinical Rheumatology, 10(5), 365–81. -
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial
Acharjee, S., Teo, K. K., Jacobs, A. K., Hartigan, P. M., Barn, K., Gosselin, G., … Boden, W. E. (2016). Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. AMERICAN HEART JOURNAL, 173, 108–17. -
Evidence-Based Management of Stable Ischemic Heart Disease Challenges and Confusion
Bangalore, S., Maron, D. J., & Hochman, J. S. (2015). Evidence-Based Management of Stable Ischemic Heart Disease Challenges and Confusion. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(18), 1917–18. -
Why Optimal Medical Therapy Should Be a Universal Standard of Care
Maron, D. J., & Boden, W. E. (2015). Why Optimal Medical Therapy Should Be a Universal Standard of Care. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(7), 774–76. -
Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia
Mancini, G. B. J., Hartigan, P. M., Shaw, L. J., Berman, D. S., Hayes, S. W., Bates, E. R., … Boden, W. E. (2014). Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia. JACC-CARDIOVASCULAR INTERVENTIONS, 7(2), 195–201. -
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial
Mancini, G. B. J., Hartigan, P. M., Bates, E. R., Chaitman, B. R., Sedlis, S. P., Maron, D. J., … Weintraub, W. S. (2013). Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. AMERICAN HEART JOURNAL, 166(3), 481–487. -
Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial)
Sedlis, S. P., Jurkovitz, C. T., Hartigan, P. M., Kolm, P., Goldfarb, D. S., Lorin, J. D., … Weintraub, W. S. (2013). Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 112(11), 1703–1708. -
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
Phillips, L. M., Hachamovitch, R., Berman, D. S., Iskandrian, A. E., Min, J. K., Picard, M. H., … Shaw, L. J. (2013). Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. JOURNAL OF NUCLEAR CARDIOLOGY, 20(6), 969–975. -
Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] Trial)
Maron, D. J., Hartigan, P. M., Neff, D. R., Weintraub, W. S., & Boden, W. E. (2013). Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] Trial). AMERICAN JOURNAL OF CARDIOLOGY, 111(11), 1557–1562. -
Revascularization for Silent Ischemia? Another Piece of the Puzzle
Maron, D. J., & Hochman, J. S. (2013). Revascularization for Silent Ischemia? Another Piece of the Puzzle. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(15), 1624–1625. -
Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
Farkouh, M. E., Boden, W. E., Bittner, V., Muratov, V., Hartigan, P., Ogdie, M., … Fuster, V. (2013). Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(15), 1607–1615. -
Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.
Henry-Okafor, Q., Collins, S. P., Jenkins, C. A., Miller, K. F., Maron, D. J., Naftilan, A. J., … Storrow, A. B. (2012). Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes. The Open Biomarkers Journal, 2012(5), 1–8. -
In Mildly Symptomatic Patients, Should an Invasive Strategy with Catheterization and Revascularization Be Routinely Undertaken? In Mildly Symptomatic Patients, an Invasive Strategy with Catheterization and Revascularization Should Not Be Routinely Undertaken
Maron, D. J., & Ting, H. H. (2013). In Mildly Symptomatic Patients, Should an Invasive Strategy with Catheterization and Revascularization Be Routinely Undertaken? In Mildly Symptomatic Patients, an Invasive Strategy with Catheterization and Revascularization Should Not Be Routinely Undertaken. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 6(1), 114–121. -
Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies
Collins, S. P., Lindsell, C. J., Jenkins, C. A., Harrell, F. E., Fermann, G. J., Miller, K. F., … Storrow, A. B. (2012). Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies. AMERICAN HEART JOURNAL, 164(6), 825–834. -
Clinical pathway: helicopter scene STEMI protocol to facilitate long-distance transfer for primary PCI.
Huang, R. L., Thomassee, E. J., Park, J. Y., Scott, C., Maron, D. J., & Fredi, J. L. (2012). Clinical pathway: helicopter scene STEMI protocol to facilitate long-distance transfer for primary PCI. Critical Pathways in Cardiology, 11(4), 193–198. -
A comparison of criterion standard methods to diagnose acute heart failure.
Collins, S. P., Lindsell, C. J., Yealy, D. M., Maron, D. J., Naftilan, A. J., McPherson, J. A., & Storrow, A. B. (2012). A comparison of criterion standard methods to diagnose acute heart failure. Congestive Heart Failure (Greenwich, Conn.), 18(5), 262–271. -
Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure.
Henry-Okafor, Q., Collins, S. P., Jenkins, C. A., Miller, K. F., Maron, D. J., Naftilan, A. J., … Storrow, A. B. (2012). Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure. The Open Biomarkers Journal, 5, 9–15. -
Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia.
Dresen, W. F., Wells, Q. S., Maron, D. J., & McPherson, J. A. (2012). Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia. Therapeutic Advances in Cardiovascular Disease, 6(3), 115–121. -
Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages
Yu, S. S., Lau, C. M., Thomas, S. N., Jerome, W. G., Maron, D. J., Dickerson, J. H., … Giorgio, T. D. (2012). Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. INTERNATIONAL JOURNAL OF NANOMEDICINE, 7, 799–813. -
The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina
Zhang, Z., Kolm, P., Boden, W. E., Hartigan, P. M., Maron, D. J., Spertus, J. A., … Weintraub, W. S. (2011). The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 4(2), 172–U72. -
Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?
Maron, D. J., Boden, W. E., Weintraub, W. S., Calfas, K. J., & O'Rourke, R. A. (2011). Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use? Current Treatment Options in Cardiovascular Medicine, 13(1), 16–25. -
Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?
Chaitman, B. R., Hartigan, P. M., Booth, D. C., Teo, K. K., Mancini, G. B. J., Kostuk, W. J., … Boden, W. E. (2010). Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System? CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(5), 476–483. -
Having It Both Ways
Bittl, J. A., & Maron, D. J. (2010). Having It Both Ways. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55(9), 865–866. -
Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial
Mancini, G. B. J., Bates, E. R., Maron, D. J., Hartigan, P., Dada, M., Gosselin, G., … Boden, W. E. (2009). Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2(4), 320–U97. -
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease
Sedlis, S. P., Jurkovitz, C. T., Hartigan, P. M., Goldfarb, D. S., Lorin, J. D., Dada, M., … Weintraub, W. S. (2009). Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease. AMERICAN JOURNAL OF CARDIOLOGY, 104(12), 1647–1653. -
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial
Teo, K. K., Sedlis, S. P., Boden, W. E., O'Rourke, R. A., Maron, D. J., Hartigan, P. M., … Weintraub, W. S. (2009). Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 54(14), 1303–1308. -
Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
Boden, W. E., O'Rourke, R. A., Teo, K. K., Maron, D. J., Hartigan, P. M., Sedlis, S. P., … Weintraub, W. S. (2009). Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 104(1), 1–4. -
Using COURAGE to treat angina.
Maron, D. J. (2008). Using COURAGE to treat angina. Medscape Journal of Medicine, 10(12), 286-? -
Health-Risk Appraisal With or Without Disease Management for Worksite Cardiovascular Risk Reduction
Maron, D. J., Forbes, B. L., Groves, J. R., Dietrich, M. S., Sells, P., & Digenio, A. G. (2008). Health-Risk Appraisal With or Without Disease Management for Worksite Cardiovascular Risk Reduction. JOURNAL OF CARDIOVASCULAR NURSING, 23(6), 513–518. -
Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients
Weintraub, W. S., Boden, W. E., Zhang, Z., Kolm, P., Zhang, Z., Spertus, J. A., … Barnett, P. G. (2008). Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 1(1), 12–U33. -
Reducing post-myocardial infarction mortality in the elderly
Boden, W. E., & Maron, D. J. (2008). Reducing post-myocardial infarction mortality in the elderly. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(13), 1255–1257. -
Does late PCI improve clinical outcome and survival in patients with arterial occlusion after MI?
Maron, D. J. (2007). Does late PCI improve clinical outcome and survival in patients with arterial occlusion after MI? NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 4(5), 250–251. -
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W., … Weintraub, W. S. (2007). The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. AMERICAN JOURNAL OF CARDIOLOGY, 99(2), 208–212. -
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424
Shaw, L. J., Heller, G. V., Casperson, P., Miranda-Peats, R., Slornka, P., Friedman, J., … Berman, D. S. (2006). Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424. JOURNAL OF NUCLEAR CARDIOLOGY, 13(5), 685–698. -
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs Cooperative Studies Program no. 424
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W., … Weintraub, W. S. (2006). Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs Cooperative Studies Program no. 424. AMERICAN HEART JOURNAL, 151(6), 1173–1179. -
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
Clark, L. T., Maki, K. C., Galant, R., Maron, D. J., Pearson, T. A., & Davidson, M. H. (2006). Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. Journal of General Internal Medicine, 21(4), 320–326. -
Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
Maron, D. J. (2004). Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels? NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 1(1), 18–19. -
Flavonoids for reduction of atherosclerotic risk.
Maron, D. J. (2004). Flavonoids for reduction of atherosclerotic risk. Current Atherosclerosis Reports, 6(1), 73–78. -
Cholesterol-lowering effect of a theaflavin-enriched green tea extract - A randomized controlled trial
Maron, D. J., Lu, G. P., Cai, N. S., Wu, Z. G., Li, Y. H., Chen, H., … Zhao, J. (2003). Cholesterol-lowering effect of a theaflavin-enriched green tea extract - A randomized controlled trial. ARCHIVES OF INTERNAL MEDICINE, 163(12), 1448–1453. -
Postexercise protein intake enhances whole-body and leg protein accretion in humans
Levenhagen, D. K., Carr, C., Carlson, M. G., Maron, D. J., Borel, M. J., & Flakoll, P. J. (2002). Postexercise protein intake enhances whole-body and leg protein accretion in humans. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 34(5), 828–837. -
The epidemiology of low levels of high-density lipoproteins cholesterol in patients with and without coronary artery disease
Maron, D. J. (2000). The epidemiology of low levels of high-density lipoproteins cholesterol in patients with and without coronary artery disease. AMERICAN JOURNAL OF CARDIOLOGY, 86(12A), 11L–14L. -
Postexercise nutrient intake timing in humans is critical to recovery of leg glucose and protein homeostasis
Levenhagen, D. K., Gresham, J. D., Carlson, M. G., Maron, D. J., Borel, M. J., & Flakoll, P. J. (2001). Postexercise nutrient intake timing in humans is critical to recovery of leg glucose and protein homeostasis. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 280(6), E982–E993. -
Self-reported cardiac risk factors in emergency department nurses and paramedics.
BARRETT, T. W., Norton, V. C., Busam, M., Boyd, J., Maron, D. J., & Slovis, C. M. (2000). Self-reported cardiac risk factors in emergency department nurses and paramedics. Prehospital and Disaster Medicine, 15(2), 14–17. -
Percutaneous coronary intervention versus medical therapy for coronary heart disease.
Maron, D. J. (2000). Percutaneous coronary intervention versus medical therapy for coronary heart disease. Current Atherosclerosis Reports, 2(4), 290–296. -
Current perspectives on statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000). Current perspectives on statins. CIRCULATION, 101(2), 207–213. -
Nonlipid primary and secondary prevention strategies for coronary heart disease
Maron, D. J. (1996). Nonlipid primary and secondary prevention strategies for coronary heart disease. CLINICAL CARDIOLOGY, 19(5), 419–423. -
PREVENTIVE MEDICINE IN PRACTICE - THE STATE OF THE ART
Maron, D. J. (1981). PREVENTIVE MEDICINE IN PRACTICE - THE STATE OF THE ART. WESTERN JOURNAL OF MEDICINE, 134(4), 367–372. -
Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)
Gosselin, G., Teo, K. K., Tanguay, J.-F., Gokhale, R., Hartigan, P. M., Maron, D. J., … Boden, W. E. (2012). Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 109(7), 954–959. -
Galectin 3 complements BNP in risk stratification in acute heart failure
Fermann, G. J., Lindsell, C. J., Storrow, A. B., Hart, K., Sperling, M., Roll, S., … Collins, S. P. (2012). Galectin 3 complements BNP in risk stratification in acute heart failure. BIOMARKERS, 17(8), 706–713. -
Can Cardiac Conduction System Disease Be Prevented?
Narayan, S. M., Baykaner, T., & Maron, D. J. (2016). Can Cardiac Conduction System Disease Be Prevented? JAMA Internal Medicine, 176(8), 1093–94. -
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2017). Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiology, 2(1), 47–54. -
Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines
Rodriguez, F., Lin, S., Maron, D. J., Knowles, J. W., Virani, S. S., & Heidenreich, P. A. (2016). Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. AMERICAN HEART JOURNAL, 182, 97–102. -
Ethnic differences in achievement of cholesterol treatment goals
Clark, L. T., Maki, K. C., Galant, R., Maron, D. J., Pearson, T. A., & Davidson, M. H. (2006). Ethnic differences in achievement of cholesterol treatment goals. JOURNAL OF GENERAL INTERNAL MEDICINE, 21(4), 320–326. -
Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease
Lui, G. K., Rogers, I. S., Ding, V. Y., Hedlin, H. K., MacMillen, K., Maron, D. J., … Fernandes, S. M. (2017). Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease. AMERICAN JOURNAL OF CARDIOLOGY, 119(1), 112–18. -
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., … Wiener, D. H. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(17), 2212–41. -
Intensity of Statin Treatment and Mortality-Reply.
Rodriguez, F., Maron, D. J., & Heidenreich, P. A. (2017). Intensity of Statin Treatment and Mortality-Reply. JAMA Cardiology. -
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons.
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. Journal of the American College of Cardiology, 69(5), 570–91. -
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 69(17), 2212–41. -
Using Commercial Programs for Lifestyle Intervention: Not Reinventing the Wheel.
Maron, D. J., & Sandhu, A. T. (2017). Using Commercial Programs for Lifestyle Intervention: Not Reinventing the Wheel. Journal of the American College of Cardiology, 70(3), 328–30. -
Dietary Patterns and Long-Term Survival: a Retrospective Study of Healthy Primary Care Patients.
Shah, N. S., Leonard, D., Finley, C. E., Rodriguez, F., Sarraju, A., Barlow, C. E., … Maron, D. J. (2017). Dietary Patterns and Long-Term Survival: a Retrospective Study of Healthy Primary Care Patients. The American Journal of Medicine. -
PREDICTORS OF STATIN USE FOR PATIENTS WITH LDL CHOLESTEROL ABOVE 190MG/DL: INSIGHTS FROM THE VETERANS AFFAIRS HEALTH CARE SYSTEM
Rodriguez, F., Knowles, J., Maron, D., Virani, S., & Heidenreich, P. (2017). PREDICTORS OF STATIN USE FOR PATIENTS WITH LDL CHOLESTEROL ABOVE 190MG/DL: INSIGHTS FROM THE VETERANS AFFAIRS HEALTH CARE SYSTEM. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(11), 1693. -
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
Maron, D. J., Hochman, J. S., O'Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., … Rosenberg, Y. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. American Heart Journal, 201, 124–35. -
Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial."
Hochman, J. S., & Maron, D. J. (2018). Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.". Circulation. Cardiovascular Quality and Outcomes, 11(4), e004742. -
Methodological Issues in "Dietary Patterns and Long-Term Survival" Reply
Leonard, D., Shah, N. S., Barlow, C. E., DeFina, L. F., Willis, B. L., & Maron, D. J. (2018). Methodological Issues in "Dietary Patterns and Long-Term Survival" Reply. AMERICAN JOURNAL OF MEDICINE, 131(5), E211. -
Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis
Bagai, A., Alexander, K. P., Berger, J. S., Senior, R., Sajeev, C., Pracon, R., … Chaitman, B. R. (2017). Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis. AMERICAN HEART JOURNAL, 190, 135–39. -
ISCHEMIA: Establishing the Primary End Point
Bangalore, S., Maron, D. J., Reynolds, H. R., Stone, G. W., O'Brien, S. M., Alexander, K. P., & Hochman, J. S. (2018). ISCHEMIA: Establishing the Primary End Point. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 11(5), e004791. -
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Zhang, Z., Jones, P., Weintraub, W. S., Mancini, G. B. J., Sedlis, S., Maron, D. J., … Spertus, J. A. (2018). Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 11(5), e003971. -
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System.
Rodriguez, F., Knowles, J. W., Maron, D. J., Virani, S. S., & Heidenreich, P. A. (2018). Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System. The American Journal of Cardiology. -
Planning and Conducting the ISCHEMIA Trial: Setting the Record Straight
Maron, D. J., Harrington, R. A., & Hochman, J. S. (2018). Planning and Conducting the ISCHEMIA Trial: Setting the Record Straight. CIRCULATION, 138(14), 1384–86. -
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.
Maron, D. J., Mancini, G. B., Hartigan, P. M., Spertus, J. A., Sedlis, S. P., Kostuk, W. J., … Boden, W. E. (2018). Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. Journal of the American College of Cardiology, 72(19), 2297–2305. -
Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial
Scudeler, T. L., Hueb, W. A., Farkouh, M. E., Maron, D. J., de Soarez, P. C., Campolina, A. G., … Kalil Filho, R. (2018). Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 273, 63–68. -
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design
Bangalore, S., Maron, D. J., Fleg, J. L., O'Brien, S. M., Herzog, C. A., Stone, G. W., … Hochman, J. S. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. AMERICAN HEART JOURNAL, 205, 42–52. -
Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals: Findings From the Cooper Center Longitudinal Study.
Rodriguez, F., Leonard, D., DeFina, L., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2018). Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals: Findings From the Cooper Center Longitudinal Study. JAMA Cardiology. -
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease (vol 24, pg 1759, 2017)
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2018). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease (vol 24, pg 1759, 2017). JOURNAL OF NUCLEAR CARDIOLOGY, 25(6), 2191–92. -
Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
Sandhu, A. T., & Maron, D. J. (2019). Coronary CT Angiography and Subsequent Risk of Myocardial Infarction. The New England Journal of Medicine, 380(3), 299. -
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2019). Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiology. -
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
Weintraub, W. S., Hartigan, P. M., Mancini, G. B., Teo, K. K., Maron, D. J., Spertus, J. A., … Boden, W. E. (2019). Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease. Circulation. Cardiovascular Quality and Outcomes, 12(2), e005079. -
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Alexander, K. P., Senior, R., … Maron, D. J. (2019). Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiology. -
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., … Allen, J. M. (2019). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 157(3), E131–E161. -
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., … Allen, J. M. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JOURNAL OF NUCLEAR CARDIOLOGY, 24(5), 1759–92. -
Relationship between simple markers of insulin resistance and coronary artery calcification
Reaven, G. M., Knowles, J. W., Leonard, D., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2017). Relationship between simple markers of insulin resistance and coronary artery calcification. JOURNAL OF CLINICAL LIPIDOLOGY, 11(4), 1007–12. -
Planning and Conducting the ISCHEMIA Trial.
Maron, D. J., Harrington, R. A., & Hochman, J. S. (2018). Planning and Conducting the ISCHEMIA Trial. Circulation, 138(14), 1384–1386. -
Using Absolute Event Rates to See What Works in Cardiovascular Medicine.
Bittl, J. A., & Maron, D. J. (2017). Using Absolute Event Rates to See What Works in Cardiovascular Medicine. Journal of the American College of Cardiology, 70(11), 1376–78. -
Preventive Interventions After Coronary Artery Calcium Scanning: Seeing is Believing.
Maron, D. J. (2017). Preventive Interventions After Coronary Artery Calcium Scanning: Seeing is Believing. JACC. Cardiovascular Imaging, 10(8), 843–44. -
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
Mancini, G. B., Maron, D. J., Hartigan, P. M., Spertus, J. A., Kostuk, W. J., Berman, D. S., … Boden, W. E. (2019). Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. Journal of the American College of Cardiology, 73(16), 2049–58. -
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes
Mancini, G. B. J., Maron, D. J., Hartigan, P. M., Spertus, J. A., Kostuk, W. J., Berman, D. S., … Boden, W. E. (2019). Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(16), 2049–58. -
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2019). Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA CARDIOLOGY, 4(3), 206–13. -
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol >= 190 mg/dl from the Veterans Affairs Health System
Rodriguez, F., Knowles, J. W., Maron, D. J., Virani, S. S., & Heidenreich, P. A. (2018). Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol >= 190 mg/dl from the Veterans Affairs Health System. AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 756–61. -
The Comparative Effect of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on 10-Year and Lifetime Atherosclerotic Cardiovascular Disease Risk.
Raygor, V., Garcia, L., Maron, D. J., & Morton, J. M. (2019). The Comparative Effect of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on 10-Year and Lifetime Atherosclerotic Cardiovascular Disease Risk. Obesity Surgery. -
Coronary artery calcium testing: A call for universal coverage.
Naghavi, M., Maron, D. J., Kloner, R. A., Berman, D. S., Budoff, M., Superko, H. R., & Shah, P. K. (2019). Coronary artery calcium testing: A call for universal coverage. Preventive Medicine Reports, 15, 100879. -
Studies Evaluating Statin Adherence and Outcome Should Adjust for Smoking Persistence and Antiplatelet Treatment Discontinuation-Reply.
Rodriguez, F., Maron, D. J., & Heidenreich, P. A. (2019). Studies Evaluating Statin Adherence and Outcome Should Adjust for Smoking Persistence and Antiplatelet Treatment Discontinuation-Reply. JAMA Cardiology. -
Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes.
Shaw, L. J., Blankstein, R., Brown, D. L., Dhruva, S. S., Douglas, P. S., Genders, T. S., … Chandrasekhar, Y. (2019). Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes. JACC. Cardiovascular Imaging, 12(7 Pt 1), 1254–78. -
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Alexander, K. P., Senior, R., … Jeffries, N. (2019). Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA CARDIOLOGY, 4(3), 273–86. -
Dietary Patterns and Long-Term Survival: A Retrospective Study of Healthy Primary Care Patients
Shah, N. S., Leonard, D., Finley, C. E., Rodriguez, F., Sarraju, A., Barlow, C. E., … Maron, D. J. (2018). Dietary Patterns and Long-Term Survival: A Retrospective Study of Healthy Primary Care Patients. AMERICAN JOURNAL OF MEDICINE, 131(1), 48–55. -
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.
Shapiro, M. D., Maron, D. J., Morris, P. B., Kosiborod, M., Sandesara, P. B., Virani, S. S., … Fazio, S. (2019). Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. Journal of the American College of Cardiology, 74(15), 1926–42. -
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine JACC Council Perspectives
Shapiro, M. D., Maron, D. J., Morris, P. B., Kosiborod, M., Sandesara, P. B., Virani, S. S., … Fazio, S. (2019). Preventive Cardiology as a Subspecialty of Cardiovascular Medicine JACC Council Perspectives. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(15), 1928–42. -
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Weintraub, W. S., Hartigan, P. M., Mancini, G. B. J., Teo, K. K., Maron, D. J., Spertus, J. A., … Boden, W. E. (2019). Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 12(2). -
Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.
Newman, J. D., Alexander, K. P., Gu, X., O'Brien, S. M., Boden, W. E., Govindan, S. C., … Maron, D. J. (2019). Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial. Circulation. Cardiovascular Quality and Outcomes, 12(11), e006002. -
Cardiorespiratory Fitness, Body-Mass Index, and Markers of Insulin Resistance in Apparently Healthy Women and Men.
Clarke, S. L., Reaven, G. M., Leonard, D., Barlow, C. E., Haskell, W. L., Willis, B. L., … Maron, D. J. (2020). Cardiorespiratory Fitness, Body-Mass Index, and Markers of Insulin Resistance in Apparently Healthy Women and Men. The American Journal of Medicine. -
Management of Coronary Disease in Patients with Advanced Kidney Disease.
Bangalore, S., Maron, D. J., O'Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., … Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease. The New England Journal of Medicine. -
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O'Brien, S. M., Fleg, J. L., … Bangalore, S. (2020). Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. The New England Journal of Medicine. -
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Boden, W. E., … Rosenberg, Y. (2020). Initial Invasive or Conservative Strategy for Stable Coronary Disease. The New England Journal of Medicine. -
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., O'Brien, S. M., Reynolds, H. R., Rosenberg, Y., … Mark, D. B. (2020). Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. The New England Journal of Medicine. -
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
Reynolds, H. R., Shaw, L. J., Min, J. K., Spertus, J. A., Chaitman, B. R., Berman, D. S., … Hochman, J. S. (2020). Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. JAMA Cardiology. -
INCIDENTAL CORONARY ARTERY CALCIFICATION IN NON-GATED CT SCANS
Sanders, M., Balla, S., Rodriguez, F., Patel, B., Eng, D. K.-M., Khandwala, N., … Maron, D. J. (2020). INCIDENTAL CORONARY ARTERY CALCIFICATION IN NON-GATED CT SCANS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(11), 1806. -
The Project Baseline Health Study: a step towards a broader mission to map human health
Arges, K., Assimes, T., Bajaj, V., Balu, S., Bashir, M. R., Beskow, L., … Wong, C. A. (2020). The Project Baseline Health Study: a step towards a broader mission to map human health. NPJ DIGITAL MEDICINE, 3(1), 84. -
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.
Boden, W. E., Hartigan, P. M., Mancini, J., Teo, K. K., Chaitman, B. R., Maron, D. J., … Weintraub, W. S. (2020). Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease. The American Journal of Cardiology. -
Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials.
Sarraju, A., Maron, D. J., & Rodriguez, F. (2020). Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials. JACC. Clinical Electrophysiology, 6(6), 739–41. -
Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
Bangalore, S., Maron, D. J., Stone, G. W., & Hochman, J. S. (2020). Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Circulation. -
Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
Lopes, R. D., Alexander, K. P., Stevens, S. R., Reynolds, H. R., Stone, G. W., Pina, I. L., … Maron, D. J. (2020). Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial. Circulation. -
Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
Antman, E. M., & Braunwald, E. (2020). Invasive or Conservative Strategy for Stable Coronary Disease. Reply. The New England Journal of Medicine, 383(10), e66. -
Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply.
Bangalore, S., Maron, D. J., & Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply. The New England Journal of Medicine, 383(11), 1091–92. -
Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop.
Greenland, P., Michos, E. D., Redmond, N., Fine, L. J., Alexander, K. P., Ambrosius, W. T., … Thanassoulis, G. (2020). Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop. JACC. Cardiovascular Imaging. -
Nurse Practitioner-Directed Cardio-Diabetes Pilot Program
Bryant, E., Janaszek, K., Nejedly, M., Li, E., Bouvier, M., Schroeder, K., … Maron, D. J. (2020). Nurse Practitioner-Directed Cardio-Diabetes Pilot Program. JNP-JOURNAL FOR NURSE PRACTITIONERS, 16(8), E123–E128. -
Invasive or Conservative Strategy for Stable Coronary Disease REPLY
Maron, D. J., & Hochman, J. S. (2020). Invasive or Conservative Strategy for Stable Coronary Disease REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 383(10). -
Management of Coronary Disease in Patients with Advanced Kidney Disease Reply
Bangalore, S., Maron, D. J., & Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease Reply. NEW ENGLAND JOURNAL OF MEDICINE, 383(11), 1091–92. -
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
Chaitman, B. R., Alexander, K. P., Cyr, D. D., Berger, J. S., Reynolds, H. R., Bangalore, S., … Hochman, J. S. (2020). Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation. -
Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy
Bangalore, S., Mancini, G. B., Leipsic, J., Budoff, M. J., Xu, Y., Anthopolos, R., … Maron, D. J. (2020). Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. -
Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.
Mancini, G. B., Leipsic, J., Budoff, M. J., Hague, C. J., Min, J. K., Stevens, S. R., … Maron, D. J. (2021). Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial. JACC. Cardiovascular Imaging. -
Digital Health Interventions for Cardiac Rehabilitation: Systematic Literature Review.
Wongvibulsin, S., Habeos, E. E., Huynh, P. P., Xun, H., Shan, R., Porosnicu Rodriguez, K. A., … Martin, S. S. (2021). Digital Health Interventions for Cardiac Rehabilitation: Systematic Literature Review. Journal of Medical Internet Research, 23(2), e18773. -
The Project Baseline Health Study: a step towards a broader mission to map human health.
Arges, K., Assimes, T., Bajaj, V., Balu, S., Bashir, M. R., Beskow, L., … Wong, C. A. (2020). The Project Baseline Health Study: a step towards a broader mission to map human health. NPJ Digital Medicine, 3(1), 84. -
Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
Bangalore, S., Maron, D. J., Stone, G. W., & Hochman, J. S. (2021). Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials". Circulation, 143(14), e809–e810. -
Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization.
Ali, Z. A., Horst, J., Gaba, P., Shaw, L. J., Bangalore, S., Hochman, J. S., … Stone, G. W. (2021). Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization. Journal of the American Heart Association, e020110. -
Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy
Bangalore, S., Mancini, G. B., Leipsic, J., Budoff, M. J., Xu, Y., Anthopolos, R., … Maron, D. J. (2020). Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. -
Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
White, H. D., O'Brien, S. M., Alexander, K. P., Boden, W. E., Bangalore, S., Li, J., … Maron, D. J. (2021). Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial. JAMA Cardiology. -
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.
Herzog, C. A., Simegn, M. A., Xu, Y., Costa, S. R., Mathew, R. O., El-Hajjar, M. C., … Bangalore, S. (2021). Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial. Journal of the American College of Cardiology. -
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design
Maron, D. J., Hochman, J. S., O'Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., … Rosenberg, Y. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. AMERICAN HEART JOURNAL, 201, 124–135. -
Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals Findings From the Cooper Center Longitudinal Study
Rodriguez, F., Leonard, D., DeFina, L., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2019). Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals Findings From the Cooper Center Longitudinal Study. JAMA CARDIOLOGY, 4(1), 43–50. -
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial
Maron, D. J., Mancini, J., Hartigan, P. M., Spertus, J. A., Sedlis, S. P., Kostuk, W. J., … Boden, W. E. (2018). Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(19), 2297–2305. -
Letter by Hochman and Maron Regarding Article, ""Faith Healing' and "Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial."
Hochman, J. S., & Maron, D. J. (2018). Letter by Hochman and Maron Regarding Article, ""Faith Healing' and "Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.". CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 11(4). -
Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
Lopes, R. D., Alexander, K. P., Hochman, J. S., & Maron, D. J. (2021). Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial". Circulation, 143(20), e961–e962. -
Automated coronary calcium scoring using deep learning with multicenter external validation.
Eng, D., Chute, C., Khandwala, N., Rajpurkar, P., Long, J., Shleifer, S., … Patel, B. N. (2021). Automated coronary calcium scoring using deep learning with multicenter external validation. NPJ Digital Medicine, 4(1), 88. -
PREDICTORS OF SETTING OF HEART FAILURE DIAGNOSIS
Tisdale, R., Stafford, R., Maron, D., Hernandez-Boussard, T., Rodriguez, F., Heidenreich, P., & Sandhu, A. (2021). PREDICTORS OF SETTING OF HEART FAILURE DIAGNOSIS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC. -
Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials.
Sarraju, A., Valencia, A., Knowles, J. W., Maron, D. J., & Rodriguez, F. (2021). Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials. Circulation, 143(24), 2409–2411. -
Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
Chaitman, B. R., Reynolds, H. R., Maron, D. J., & Hochman, J. S. (2021). Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons". Circulation, 144(2), e14–e15. -
Disparity in the Setting of Incident Heart Failure Diagnosis.
Sandhu, A. T., Tisdale, R. L., Rodriguez, F., Stafford, R. S., Maron, D. J., Hernandez-Boussard, T., … Heidenreich, P. A. (2021). Disparity in the Setting of Incident Heart Failure Diagnosis. Circulation. Heart Failure, CIRCHEARTFAILURE121008538. -
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
Reynolds, H. R., Shaw, L. J., Min, J. K., Page, C. B., Berman, D. S., Chaitman, B. R., … Hochman, J. S. (2021). Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. Circulation. -
Outcomes of Participants with Diabetes in the ISCHEMIA Trials.
Newman, J. D., Anthopolos, R., Mancini, G. B., Bangalore, S., Reynolds, H. R., Kunichoff, D. F., … Maron, D. J. (2021). Outcomes of Participants with Diabetes in the ISCHEMIA Trials. Circulation. -
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
Lopez-Sendon, J. L., Cyr, D. D., Mark, D. B., Bangalore, S., Huang, Z., White, H. D., … O'Brien, S. M. (2021). Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. European Heart Journal. -
Predictors of Outcome in the ISCHEMIA-CKD Trial: Anatomy versus Ischemia.
Bainey, K. R., Fleg, J. L., Hochman, J. S., Kunichoff, D. F., Anthopolos, R., Chernyavskiy, A. M., … Bangalore, S. (2021). Predictors of Outcome in the ISCHEMIA-CKD Trial: Anatomy versus Ischemia. American Heart Journal. -
Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
Reynolds, H. R., Picard, M. H., Spertus, J. A., Peteiro, J., Lopez Sendon, J. L., Senior, R., … Hochman, J. S. (2021). Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study. Circulation, 144(13), 1008–1023. -
The Glass Is at Least Half Full.
Maron, D. J., Bangalore, S., & Hochman, J. S. (2021). The Glass Is at Least Half Full. JACC. Cardiovascular Interventions, 14(21), 2350–2352. -
Time to Relax the 40-Year Age Threshold for Pharmacologic Cholesterol Lowering.
Heidenreich, P. A., Clarke, S. L., & Maron, D. J. (2021). Time to Relax the 40-Year Age Threshold for Pharmacologic Cholesterol Lowering. Journal of the American College of Cardiology, 78(20), 1965–1967. -
Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study.
Califf, R. M., Wong, C., Doraiswamy, P. M., Hong, D. S., Miller, D. P., & Mega, J. L. (2022). Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study. BMJ Open, 12(1), e054741. -
Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
Sidhu, M. S., Alexander, K. P., Huang, Z., O'Brien, S. M., Chaitman, B. R., Stone, G. W., … Maron, D. J. (2022). Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial. American Heart Journal. -
Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement?.
Budoff, M. J., Lakshmanan, S., Toth, P. P., Hecht, H. S., Shaw, L. J., Maron, D. J., … Blaha, M. (2022). Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement?. American Journal of Preventive Cardiology, 9, 100318. -
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.
Senior, R., Reynolds, H. R., Min, J. K., Berman, D. S., Picard, M. H., Chaitman, B. R., … Hochman, J. S. (2022). Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial. Journal of the American College of Cardiology, 79(7), 651–661. -
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
Briguori, C., Mathew, R. O., Huang, Z., Mavromatis, K., Hickson, L. T. J., Lau, W. L., … Bangalore, S. (2022). Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD. Journal of the American Heart Association, e022003. -
Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
Mark, D. B., Spertus, J. A., Bigelow, R., Anderson, S., Daniels, M. R., Anstrom, K. J., … Hochman, J. S. (2022). Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA. Circulation. -
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.
Bangalore, S., Spertus, J. A., Stevens, S. R., Jones, P. G., Mancini, G. B., Leipsic, J., … Maron, D. J. (2022). Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial. Circulation. Cardiovascular Interventions, CIRCINTERVENTIONS121010925. -
Timing of Statin Dose: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Haisum Maqsood, M., Messerli, F. H., Waters, D., Skolnick, A. H., Maron, D. J., & Bangalore, S. (2022). Timing of Statin Dose: A Systematic Review and Meta-analysis of Randomized Clinical Trials. European Journal of Preventive Cardiology. -
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
Bangalore, S., Hochman, J. S., Stevens, S. R., Jones, P. G., Spertus, J. A., O'Brien, S. M., … Maron, D. J. (2022). Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. JAMA Cardiology. -
Multi-dimensional characterization of prediabetes in the Project Baseline Health Study.
Chatterjee, R., Kwee, L. C., Pagidipati, N., Koweek, L. H., Mettu, P. S., Haddad, F., … Shah, S. H. (2022). Multi-dimensional characterization of prediabetes in the Project Baseline Health Study. Cardiovascular Diabetology, 21(1), 134. -
Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline.
Cardoso, R., Shaw, L. J., Blumenthal, R. S., Nasir, K., Ferraro, R., Maron, D. J., … Blankstein, R. (2022). Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline. American Journal of Preventive Cardiology, 11, 100365. -
Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study.
Haddad, F., Cauwenberghs, N., Daubert, M. A., Kobayashi, Y., Bloomfield, G. S., Fleischman, D., … Douglas, P. S. (2022). Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study. Journal of Cardiovascular Computed Tomography. -
Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Smilowitz, N. R., Carey, E. P., Shah, B., Hartigan, P. M., Plomondon, M. E., Maron, D. J., … Boden, W. E. (2022). Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. The American Journal of Cardiology. -
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
Chaitman, B. R., Cyr, D. D., Alexander, K. P., Pracon, R., Bainey, K. R., Mathew, A., … Bangalore, S. (2022). Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. Circulation. Cardiovascular Interventions, 15(8), e012103. -
Screening for participants in the ISCHEMIA trial: Implications for clinical research
Rodriguez, F., Hochman, J. S., Xu, Y., Reynolds, H. R., Berger, J. S., Mavromichalis, S., … Maron, D. J. (2022). Screening for participants in the ISCHEMIA trial: Implications for clinical research. JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 6(1). -
Association of Medication Adherence With Health Outcomes in the ISCHEMIATrial.
Garcia, R. A., Spertus, J. A., Benton, M. C., Jones, P. G., Mark, D. B., Newman, J. D., … Maron, D. J. (2022). Association of Medication Adherence With Health Outcomes in the ISCHEMIATrial. Journal of the American College of Cardiology, 80(8), 755–765. -
Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients.
Greenland, P., Maron, D. J., & Budoff, M. J. (2022). Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients. Circulation, 146(8), 585–586. -
Revascularization and survival in multivessel coronary artery disease in ischemia.
Maron, D. J., Bangalore, S., Reynolds, H. R., & Hochman, J. S. (2022). Revascularization and survival in multivessel coronary artery disease in ischemia. JTCVS Open, 10, 243. -
Screening for participants in the ISCHEMIA trial: Implications for clinical research.
Rodriguez, F., Hochman, J. S., Xu, Y., Reynolds, H. R., Berger, J. S., Mavromichalis, S., … Maron, D. J. (2022). Screening for participants in the ISCHEMIA trial: Implications for clinical research. Journal of Clinical and Translational Science, 6(1), e90. -
Ischemia With Nonobstructive CoronaryArteries: Insights From the ISCHEMIA Trial.
Reynolds, H. R., Diaz, A., Cyr, D. D., Shaw, L. J., Mancini, G. B., Leipsic, J., … Maron, D. J. (2022). Ischemia With Nonobstructive CoronaryArteries: Insights From the ISCHEMIA Trial. JACC. Cardiovascular Imaging. -
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
Mathew, R. O., Maron, D. J., Anthopolos, R., Fleg, J. L., O'Brien, S. M., Rockhold, F. W., … Bangalore, S. (2022). Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circulation. Cardiovascular Quality and Outcomes, 101161CIRCOUTCOMES122008995. -
ISCHEMIA-EXTEND Studies: Rationale and Design.
Anthopolos, R., Maron, D. J., Bangalore, S., Reynolds, H. R., Xu, Y., O'Brien, S. M., … Hochman, J. S. (2022). ISCHEMIA-EXTEND Studies: Rationale and Design. American Heart Journal. -
Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials.
Mavromatis, K., Boden, W. E., Maron, D. J., Mancini, G. B., Weintraub, W. S., Gosselin, G., … Hochman, J. S. (2022). Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials. The American Journal of Cardiology. -
Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke.
Sandhu, A. T., Rodriguez, F., Maron, D. J., & Heidenreich, P. A. (2022). Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke. American Journal of Preventive Cardiology, 12, 100426. -
Opportunistic Incidence Prediction of Multiple Chronic Diseases from Abdominal CT Imaging Using Multi-task Learning
Blankemeier, L., Gallegos, I., Chaves, J. M. Z., Maron, D., Sandhu, A., Rodriguez, F., … Chaudhari, A. S. (2022). Opportunistic Incidence Prediction of Multiple Chronic Diseases from Abdominal CT Imaging Using Multi-task Learning. MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION, MICCAI 2022, PT VII. SPRINGER INTERNATIONAL PUBLISHING AG. -
Survival After Invasive or Conservative Management of Stable Coronary Disease.
Hochman, J. S., Anthopolos, R., Reynolds, H. R., Bangalore, S., Xu, Y., O'Brien, S. M., … Maron, D. J. (2022). Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation. -
Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project).
Sandhu, A. T., Rodriguez, F., Ngo, S., Patel, B. N., Mastrodicasa, D., Eng, D., … Maron, D. J. (2022). Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project). Circulation. -
Coronary Atherosclerosis Burden and Progression to Guide Clinical Decision Making: A Report from the American College of Cardiology Innovations in Prevention Working Group.
Freeman, A. M., Raman, S. V., Aggarwal, M., Maron, D. J., Bhatt, D. L., Parwani, P., … Shapiro, M. D. (2022). Coronary Atherosclerosis Burden and Progression to Guide Clinical Decision Making: A Report from the American College of Cardiology Innovations in Prevention Working Group. The American Journal of Medicine. -
Disparities in Adoption of New Diabetic Therapies with Cardiovascular Benefits.
Vasti, E. C., Basina, M., Calma, J., Maron, D. J., Rodriguez, F., & Sandhu, A. T. (2022). Disparities in Adoption of New Diabetic Therapies with Cardiovascular Benefits. Diabetes Research and Clinical Practice, 110233. -
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
Sidhu, M. S., Alexander, K. P., Huang, Z., Mathew, R. O., Newman, J. D., O'Brien, S. M., … Bangalore, S. (2023). Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial. JACC. Cardiovascular Interventions, 16(2), 209–218. -
Predictors of Incident HeartFailure Diagnosis Setting: Insights From the Veterans Affairs Healthcare System.
Tisdale, R. L., Fan, J., Calma, J., Cyr, K., Podchiyska, T., Stafford, R. S., … Sandhu, A. T. (2022). Predictors of Incident HeartFailure Diagnosis Setting: Insights From the Veterans Affairs Healthcare System. JACC. Heart Failure. -
Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-Gated Chest Cts to Improve Statin Rates
Sandhu, A. T., Rodriguez, F., Ngo, S., Patel, B., Mastrodicasa, D., Eng, D. T., … Maron, D. J. (2022). Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-Gated Chest Cts to Improve Statin Rates. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. -
ISCHEMIA-EXTENDed Follow-Up Interim Report
Hochman, J. S., Maron, D. J., Anthopolos, R., Xu, Y., Reynolds, H., Bangalore, S., … Senior, R. (2022). ISCHEMIA-EXTENDed Follow-Up Interim Report. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. -
Corrigendum to 'Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making' The American Journal of Medicine 136:03 (2023); 260-269.e7.
Freeman, A. M., Raman, S. V., Aggarwal, M., Maron, D. J., Bhatt, D. L., Parwani, P., … Shapiro, M. D. (2023). Corrigendum to 'Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making' The American Journal of Medicine 136:03 (2023); 260-269.e7. The American Journal of Medicine. -
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.
Nguyen, D. D., Spertus, J. A., Alexander, K. P., Newman, J. D., Dodson, J. A., Jones, P. G., … Hochman, J. S. (2023). Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. Journal of the American College of Cardiology, 81(17), 1697–1709. -
Strategies to Mitigate Emergency Department Crowding and Its Impact on Cardiovascular Patients.
Baugh, C. W., Freund, Y., Steg, P. G., Body, R., Maron, D. J., & Yiadom, M. Y. (2023). Strategies to Mitigate Emergency Department Crowding and Its Impact on Cardiovascular Patients. European Heart Journal. Acute Cardiovascular Care. -
SOCIAL DETERMINANTS OF HEALTH AND CORONARY ARTERY CALCIUM: RESULTS FROM THE PROJECT BASELINE HEALTH STUDY
Dudum, R., Ling, A., Short, S., Koweek, L. H., Carroll, M., Daubert, M. A., … Rodriguez, F. (2023). SOCIAL DETERMINANTS OF HEALTH AND CORONARY ARTERY CALCIUM: RESULTS FROM THE PROJECT BASELINE HEALTH STUDY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC. -
OPPORTUNISTIC SCREENING OF INCIDENTAL CORONARY ARTERY CALCIUM WITH DEEP-LEARNING ALGORITHM ON NON-ECG GATED CHEST CT IMAGING AND ASSOCIATION WITH CARDIOVASCULAR EVENTS AND MORTALITY
Peng, A., Dudum, R., Maron, D. J., Sandhu, A., & Rodriguez, F. (2023). OPPORTUNISTIC SCREENING OF INCIDENTAL CORONARY ARTERY CALCIUM WITH DEEP-LEARNING ALGORITHM ON NON-ECG GATED CHEST CT IMAGING AND ASSOCIATION WITH CARDIOVASCULAR EVENTS AND MORTALITY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC. -
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.
Mavromatis, K., Jones, P. G., Ali, Z. A., Stone, G. W., Rhodes, G. M., Bangalore, S., … Spertus, J. A. (2023). Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial. Journal of the American College of Cardiology, 82(4), 295–313. -
Impact of Complete Revascularization inthe ISCHEMIA Trial.
Stone, G. W., Ali, Z. A., O'Brien, S. M., Rhodes, G., Genereux, P., Bangalore, S., … Maron, D. J. (2023). Impact of Complete Revascularization inthe ISCHEMIA Trial. Journal of the American College of Cardiology. -
Response by Sandhu et al to Letter Regarding Article, "Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)".
Sandhu, A. T., Rodriguez, F., & Maron, D. J. (2023). Response by Sandhu et al to Letter Regarding Article, "Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)". Circulation, 148(5), 441. -
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials: Biomarkers and risk prediction in stable coronary artery disease. A post-hoc secondary analysis from the ISCHEMIA randomized clinical trial biorepository.
Newman, J. D., Anthopolos, R., Ruggles, K. V., Cornwell, M., Reynolds, H. R., Bangalore, S., … Berger, J. S. (2023). Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials: Biomarkers and risk prediction in stable coronary artery disease. A post-hoc secondary analysis from the ISCHEMIA randomized clinical trial biorepository. American Heart Journal. -
Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging With Cardiovascular Outcomes.
Peng, A. W., Dudum, R., Jain, S. S., Maron, D. J., Patel, B. N., Khandwala, N., … Rodriguez, F. (2023). Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging With Cardiovascular Outcomes. Journal of the American College of Cardiology, 82(12), 1192–1202. -
Global Longitudinal Strain as Predictor of Inducible Ischemia in No Obstructive Coronary Artery Disease in the CIAO-ISCHEMIA study.
Davis, E. F., Crousillat, D. R., Peteiro, J., Lopez-Sendon, J., Senior, R., Shapiro, M. D., … Reynolds, H. R. (2023). Global Longitudinal Strain as Predictor of Inducible Ischemia in No Obstructive Coronary Artery Disease in the CIAO-ISCHEMIA study. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. -
Readability and reliability of online patient education materials about statins.
Ngo, S., Asirvatham, R., Baird, G. L., Sarraju, A., Maron, D. J., & Rodriguez, F. (2023). Readability and reliability of online patient education materials about statins. American Journal of Preventive Cardiology, 16, 100594. -
BMI and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in ISCHEMIA-CKD.
Mathew, R. O., Kretov, E. I., Huang, Z., Jones, P. G., Sidhu, M. S., O'Brien, S. M., … Bangalore, S. (2023). BMI and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in ISCHEMIA-CKD. The American Journal of Medicine. -
Opportunistic assessment of ischemic heart disease risk using abdominopelvic computed tomography and medical record data: a multimodal explainable artificial intelligence approach.
Zambrano Chaves, J. M., Wentland, A. L., Desai, A. D., Banerjee, I., Kaur, G., Correa, R., … Patel, B. N. (2023). Opportunistic assessment of ischemic heart disease risk using abdominopelvic computed tomography and medical record data: a multimodal explainable artificial intelligence approach. Scientific Reports, 13(1), 21034. -
REPLY: Interpreting the Impactof Complete Revascularization in theISCHEMIATrial.
Stone, G. W., Ali, Z. A., Hochman, J. S., & Maron, D. J. (2024). REPLY: Interpreting the Impactof Complete Revascularization in theISCHEMIATrial. Journal of the American College of Cardiology, 83(4), e39–e40. -
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Reynolds, H. R., Cyr, D. D., Merz, C. N., Shaw, L. J., Chaitman, B. R., Boden, W. E., … Hochman, J. S. (2024). Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial. Journal of the American Heart Association, e029850. -
Contemporary attitudes and beliefs on coronary artery calcium from social media using artificial intelligence.
Somani, S., Balla, S., Peng, A. W., Dudum, R., Jain, S., Nasir, K., … Rodriguez, F. (2024). Contemporary attitudes and beliefs on coronary artery calcium from social media using artificial intelligence. NPJ Digital Medicine, 7(1), 83. -
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
Nurmohamed, N. S., van Rosendael, A. R., Danad, I., Ngo-Metzger, Q., Taub, P. R., Ray, K. K., … Bhatt, D. L. (2024). Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography. European Heart Journal. -
Variation in Health Status With Invasivevs Conservative Management ofChronic Coronary Disease.
Arnold, S. V., Jones, P. G., Maron, D. J., Cohen, D. J., Mark, D. B., Reynolds, H. R., … Spertus, J. A. (2024). Variation in Health Status With Invasivevs Conservative Management ofChronic Coronary Disease. Journal of the American College of Cardiology, 83(15), 1353–1366. -
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracon, R., Spertus, J. A., Broderick, S., Bangalore, S., Rockhold, F. W., Ruzyllo, W., … Maron, D. J. (2024). Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial. Circulation. Cardiovascular Interventions, e013435. -
Equity in the Setting of Heart Failure Diagnosis: An Analysis of Differences Between and Within Clinician Practices.
Gupta, A., Tisdale, R. L., Calma, J., Stafford, R. S., Maron, D. J., Hernandez-Boussard, T., … Sandhu, A. T. (2024). Equity in the Setting of Heart Failure Diagnosis: An Analysis of Differences Between and Within Clinician Practices. Circulation. Heart Failure, e010718. -
Cardiometabolic Comorbidity Burden and Circulating Biomarkers in Patients with Chronic Coronary Disease in the ISCHEMIA Trials.
Hamo, C. E., Liu, R., Wu, W., Anthopolos, R., Bangalore, S., Held, C., … Berger, J. S. (2024). Cardiometabolic Comorbidity Burden and Circulating Biomarkers in Patients with Chronic Coronary Disease in the ISCHEMIA Trials. The American Journal of Cardiology. -
AI-enabled Cardiac Chambers Volumetry and Calcified Plaque Characterization in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Naghavi, M., Reeves, A., Atlas, K., Zhang, C., Atlas, T., Henschke, C., … Wong, N. (2024). AI-enabled Cardiac Chambers Volumetry and Calcified Plaque Characterization in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Research Square. -
Characterization of Peripheral Artery Disease and Associations with Traditional Risk Factors, Mobility, and Biomarkers in the Project Baseline Health Study.
Kercheval, J. B., Narcisse, D. I., Nguyen, M., Rao, S. V., Gutierrez, J. A., Leeper, N. J., … Swaminathan, R. V. (2024). Characterization of Peripheral Artery Disease and Associations with Traditional Risk Factors, Mobility, and Biomarkers in the Project Baseline Health Study. American Heart Journal. -
Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
Fleg, J. L., Huang, Z., Reynolds, H. R., Shaw, L. J., Chaitman, B. R., O'Brien, S. M., … Hochman, J. S. (2024). Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA. Circulation, 150(2), 165–167. -
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
Nurmohamed, N. S., Min, J. K., Anthopolos, R., Reynolds, H. R., Earls, J. P., Crabtree, T., … Maron, D. J. (2024). Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial. European Heart Journal. -
Sociodemographic Differences Among Patients Receiving Coronary Artery Calcium Imaging vs Nongated Chest Computed Tomography Imaging.
Peng, A. W., Skye, M., Jain, S. S., Dudum, R., Maron, D. J., Din, N., … Rodriguez, F. (2024). Sociodemographic Differences Among Patients Receiving Coronary Artery Calcium Imaging vs Nongated Chest Computed Tomography Imaging. JACC. Advances, 3(7), 100963. -
Low-Density Lipoprotein Cholesterol Control as a Performance Measure: A National Analysis of the VHA.
Jain, S. S., Skye, M., Din, N., Furst, A., Maron, D. J., Heidenreich, P., … Rodriguez, F. (2024). Low-Density Lipoprotein Cholesterol Control as a Performance Measure: A National Analysis of the VHA. Journal of the American College of Cardiology, 84(13), 1272–1275. -
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Ikemura, N., Spertus, J. A., Nguyen, D., Fu, Z., Jones, P. G., Reynolds, H. R., … Maron, D. J. (2024). International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial. Circulation. Cardiovascular Quality and Outcomes, e010534. -
Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods Study.
Nguyen, D. D., Decker, C., Pacheco, C. M., Farr, S. L., Fuss, C., Masterson Creber, R. M., … Spertus, J. A. (2024). Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods Study. Circulation. Cardiovascular Quality and Outcomes, e010923. -
Seeing Is Knowing: Noninvasive Imaging Outperforms Traditional Risk Assessment.
Maron, D. J., & Rodriguez, F. (2024). Seeing Is Knowing: Noninvasive Imaging Outperforms Traditional Risk Assessment. Journal of the American College of Cardiology, 84(15), 1404–1406. -
Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action.
Maron, D. J., Budoff, M. J., Sky, J. C., Bommer, W. J., Epstein, S. D., Fisher, D. A., … DeMaria, A. N. (2024). Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action. JACC. Advances, 3(11), 101287. -
Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023
Gomez, S. E., Furst, A., Chen, T., Din, N., Maron, D. J., Heidenreich, P., … Rodriguez, F. (2024). Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023. AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 20. -
Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023.
Gomez, S. E., Furst, A., Chen, T., Din, N., Maron, D. J., Heidenreich, P., … Rodriguez, F. (2024). Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023. American Journal of Preventive Cardiology, 20, 100872. -
Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial.
Bangalore, S., Rhodes, G., Maron, D. J., Anthopolos, R., O'Brien, S. M., Jones, P. G., … Ischemia Research Group, O. B. (2024). Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial. EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 20(20), e1276–e1287. -
LOW-DENSITY LIPOPROTEIN CHOLESTEROL TESTING AND CONTROL AS PERFORMANCE METRICS: A NATIONAL ANALYSIS OF VETERANS AFFAIRS HEALTH CARE SYSTEMS
Jain, S. S., Skye, M., Din, N., Maron, D. J., Heidenreich, P. A., Kalwani, N., … Rodriguez, F. (2024). LOW-DENSITY LIPOPROTEIN CHOLESTEROL TESTING AND CONTROL AS PERFORMANCE METRICS: A NATIONAL ANALYSIS OF VETERANS AFFAIRS HEALTH CARE SYSTEMS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC. -
Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction.
Naghavi, M., Reeves, A. P., Atlas, K., Zhang, C., Atlas, T., Henschke, C. I., … Wong, N. D. (2024). Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction. NPJ Digital Medicine, 7(1), 309. -
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Reynolds, H. R., Page, C. B., Shaw, L. J., Berman, D. S., Chaitman, B. R., Picard, M. H., … Hochman, J. S. (2024). Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial. Circulation. Cardiovascular Interventions, 17(12), e013743. -
Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES
Geba, G. P., Chen, R., Talapatra, K., Brackin, T., Mohammadi, K. A., Pordy, R., … Fazio, S. (2024). Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES. AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 20. -
Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES.
Geba, G. P., Chen, R., Talapatra, K., Brackin, T., Mohammadi, K. A., Pordy, R., … Fazio, S. (2024). Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES. American Journal of Preventive Cardiology, 20, 100900. -
Lipoprotein a Testing Patterns in the Veterans Health Administration.
Chen, T., Furst, A., Din, N., Gomez, S., Maron, D. J., Heidenreich, P., … Rodriguez, F. (2025). Lipoprotein a Testing Patterns in the Veterans Health Administration. JAMA Network Open, 8(1), e2453300. -
Sex Differences in Psychosocial Factors and Angina in Patients With Chronic Coronary Disease.
Hausvater, A., Anthopolos, R., Seltzer, A., Spruill, T. M., Spertus, J. A., Peteiro, J., … Reynolds, H. R. (2025). Sex Differences in Psychosocial Factors and Angina in Patients With Chronic Coronary Disease. Journal of the American Heart Association, e037909. -
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Slater, J., Maron, D. J., Jones, P. G., Bangalore, S., Reynolds, H. R., Fu, Z., … Spertus, J. A. (2025). Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial. Circulation. Cardiovascular Quality and Outcomes, e010849. -
Stress Echocardiography in Patients with Moderate or Severe Myocardial Ischemia: Insights from the ISCHEMIA Trial.
Picard, M. H., Saysana, K., Cyr, D. D., Zeng, X., Scherrer-Crosbie, M., Shaw, L. J., … Reynolds, H. R. (2025). Stress Echocardiography in Patients with Moderate or Severe Myocardial Ischemia: Insights from the ISCHEMIA Trial. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. -
Invasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA Trial.
Bangalore, S., Mancini, G. B., Leipsic, J., Budoff, M. J., Xu, Y., Anthopolos, R., … Maron, D. J. (2025). Invasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA Trial. Journal of the American College of Cardiology, 85(12), 1335–1349. -
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.
Maron, D. J., Newman, J. D., Anthopolos, R., Lu, Y., Stevens, S., Boden, W. E., … Hochman, J. S. (2025). Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial. Journal of the American College of Cardiology, 85(12), 1317–1331. -
Quantitative Coronary Artery Plaque Parameters and Severity of Ischemia in Patients With INOCA.
Lerner, J. B.-A., Pleasure, M., Min, J. K., Picard, M. H., Peteiro, J., Senior, R., … Reynolds, H. R. (2025). Quantitative Coronary Artery Plaque Parameters and Severity of Ischemia in Patients With INOCA. Circulation. Cardiovascular Imaging, e017367. -
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality: an AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA).
Naghavi, M., Atlas, K., Reeves, A., Zhang, C., Wasserthal, J., Atlas, T., … Wong, N. D. (2025). AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality: an AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA). BMJ Open Diabetes Research & Care, 13(2). -
Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository.
Muller, M., Liu, R., Shah, F., Hu, J., Held, C., Kullo, I. J., … Newman, J. D. (2025). Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository. Circulation. Genomic and Precision Medicine, e004921.
-
Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Preventive Cardiology Palo Alto, CA
Palo Alto, CA
Preventive Cardiology
300 Pasteur Dr, Fl 2 Rm A260
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereHypertension Center Palo Alto, CA
Palo Alto, CA
Hypertension Center
300 Pasteur Dr, Fl 1 Ste A11
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(180 reviews)
Excellent communication, very helpful session.
I appreciate the option to do a video visit. Very helpful with busy schedules
Dr. Maron conducted a very thorough review of my health state and treatment and provided very helpful future suggestions.
Dr Maron always provides much needed information on the new research, statistics, data analysis and other helpful insights into new treatments and drug discovery to support my understanding and health care advances which I have come to appreciate and respect because he is always making my health/heart better.
Dr Maron was a delight. He is incredibly humble and brilliant at the same time, rare combination.
Amazing. Thoughtful, helpful, respectful, smart.
Dr Maron took his time and answered all my questions. He was very easy to speak with. I felt he was genuinely concerned about my health.
Excellent experience with Dr. Marion.
I am very fortunate to have Dr. Maron as my caregiver.
Dr. Moran was very informative and I felt much a mentor in helping me understand my condition and options. I'm very pleased.
Thank you. I really appreciated you going over the literature with me.
Very respectful, knowledgable, pleasant and helpful.
Dr, Maron is warm, thoughtful, insightful, knowledgeable, and mellow. I am delighted to be on the receiving end of his medical expertise. Thank you!
He is a very thorough and caring during our appointment. I feel comfortable and at ease having Dr. Maron helping me.
He is great!
Dr. Maron does his homework and can give full attention to the patient. He has thought thru the various options and opprotunities.
He was thoughtful, easy to talk and seemed genuinely interested in my case even though we only see each other once a year.
Dr Maron is an exceptional physician
Thoughtful intelligent with an excellent bedside manner
Dr Maron is thoughtful, knowledgeable, and caring. He is the model I wish every physician would follow!
Dr. Maron is an excellent and compassionate physician. He is an important asset for Stanford.
Excellent
He is thoughtful, current, patient, sympathetic, and in command of the subject matter.
Dr Maron is an excellent Cardilogist that cares about his patients and provides timely medical advice leveraging his vast experience base and best medical technology available.
Excellent.
He is great - much appreciated!
Superb bedside manner and an exceptional physician.
Thorough and excellent job by Dr. Maron.
He’s a very good and intelligent man who cares while knowing how difficult some patients can be when confused with conflicting information from others.
He is very friendly, kind, explain velyclare..
Dr David Maron is a very caring and efficient doctor.
Dr. Maron is a good listener and understood what I wanted to communicate to him. He seems caring and interested in helping me resolve my issues.
He was great and spent more time than I anticipated. Couldn’t have been any better!
EXCELLENT AT EXPLAINING MEDICAL ISSUES.
Incredibly thoughtful, informed, prepared, sympathetic and skilled. Dr. Maron "walks on water."
I wish all my doctors were as good as Dr Maron. I feel fortunate to have the opportunity to meet with him. He has the right level of 'bedside manners' (polite), combined with direct and understandable feedback and recommendations. He talks to me, not at me.
Thank you.
Dr. Maron provided excellent, thorough care. He took a full family history, explained everything in terms I could understand, and had a fantastic bedside manner. I am aware of all the follow up steps I need to take after our visit. I can recommend him in the most glowing terms.
He was great. A gentleman.
Very personable, clarified all issues well and was genuinely interested to be helpful and encouraging.
He's an excellent physician.
Dr.Maron is a great medical doctor - knowledgeable, experienced, attentive, and caring,
Very thoughtful discussion. Really listened to my concerns.
An excellent doctor - consultant who is very knowledgeable and thoughtful about his patients and their health.
He is the best personin my life
Fabulous
Absolutely superb physician and good listener.
Thanks for everything
Excellent visit.
I met him for the first time during video visit. Ho knows what he is doing.
Excellent explain and easy to understand details
He is fantastic. Truly a top-notch doctor and incredible human being.
Dr. Moran is a caring, supportive, patient, well educated physician. I feel confident and valued in his care. He is a great contributor to Stanford Medicine and the patients he counsels and treats.
Great doctor, very easy to understand, took time to answer all my questions.
Dr Maron is a wonderful physician; both in terms of knowledge as well as his empathy/bedside manner. I feel very fortunate to have been able to spend an hour with him.
I really like him. Very knowledgeable and easy to talk with.
Professional and competent
I appreciated the careful consideration Dr. Maron gave to all aspects of my health issues, as well as making a recommendation for my daughter's management of familial hypercholesterolemia.
Very thorough and clear. He was well prepared and clearly had studied my records and forms. Provided good suggestions and laid out next steps. A very worthwhile experience for me.
I'm so pleased and privileged having Dr. Maron as my provider. Dr. Maron, thank you for being so caring and considerate. Furthermore, I would like to thank Stanford Cardiology group for maintaining such a high standard.
Dr. Maron is a very sensitive and caring doctor with an extensive knowledge in his chosen field of cardiology. I would recommend him to other patients without qualification.
Dr. Maron has saved my life from a potential death due to a heart attack episode and the accompanied internal bleeding symptom in February, 2023. I am greatly grateful for his help and kindness in the time when I was on a total vulnerable and helpless circumstance.
He is absolutely an OUTSTANDING physician, caring, compassionate. Very well informative. He took time to explain and answered questions. Very calm. Very knowledgeable. Provides absolutely excellent CARE. He really represents Stanford as it stands and well known. We are very fortunate to have him as physician. We trust him!! Thank you for having him as Stanford physician. He provides care with PRIDE.
He is fantastic!
Very helpful and an excellent encounter
Excellent and caring MD
Dr. Maron was excellent! Rarely have I ever met a physician who is so compassionate, well-versed in their subject area, and detail-oriented in their note taking and questions. This was one of the best medical sessions I have ever had. Dr. Maron's empathy and care for helping patients was apparent. I am truly grateful for this extraordinary level of care.
- Piya Sorcar
He's utterly fantastic. Very patient with questions, explains things really welll, is a true scientist, and clearly cares about his patients.
He is very patient to his patient
Thank you for the very informative visit, doctor!
As a preventative cardiologist, Dr. Maron is wonderful, patient, knowledgeable and attentive. I'd highly recommend Dr. Maron .
Dr. Maron is an excellent doctor who cares about his patients. He is attentive, thoughtful, and a clear communicator. And he is a pleasure to speak with. I have a great respect for him as a medical doctor and a human being.
Dr. Maron is the one of the best doctors I've dealt with. I really like his caring, analysis, recommendations. I very highly recommend him to anyone who has heart issues. His rating is 10+++
Competent and knowledgeable.
I always appreciate how Dr Maron takes time our of his buys day to meet with his patients. He never rushes the appointment and is always thorough. It is clear he cares deeply about his patients’ well-being.
Excellent care
Excellent consultation.Thank you
The best and most compassionate doctor ever
He was prepared for the appointment. He apologized for being slightly late. He had helpful observattions about my condition.
Excellent
Very comfortable to work with.
Dr. Maron is a consummate professional.
terrific visit. Expert information.
I appreciated his background work on me and the conversational nature of his explanations.
Outstanding, compassionate, caring physician
Thought he gave me useful information and he was quite personable as well. I enjoyed my consult.
Dr Maron was excellent in assessing my current status and discussing path forward. He took the time necessary to address all my questions.
I appreciate the time he took to talk to me about my concerns. I like that he had an alternate plan to offer me
Dr. David Moran provides excellent medical counsel. He is patient, understanding and gets to the core of matters to receive a successful end result. He has assisted me with catapulting my cardiovascular health to a level I haven’t achieved in quite some time. I am very grateful for his knowledge and expertise in navigating me.
THE VERY BEST God bless
Excellent listening skills and advice. Followed up afterwards in person.
Thank you Dr. Maron.
He is an excellent doctor. He's caring, a good listener, and very knowledgeable.
Dr Marin was very patient with my hard hearing problems and extremely thorough considering all issues I had.
Dr. Maron was both professional and friendly, listened carefully, asked questions regarding my comments, explained what some options were and the reasons behind his choice.
Dr Maron is an kind, intelligent, knowledgeable doctor that I am extremely lucky to have as my doctor.
David is an excellent cardiologist. He listens very well and responds clearly and thoroughly to all my questions. I often ask questions about diet or other issues related to cardiac health and he always answers them clearly.
I really appreciate how generous he is with his time. I feel I have his full focus and attention. He is very well prepared for my appointment and knows all my relevant personal health details.
He is thoughtful kind and warm. I would highly recommend him to anyone I know for his excellence as a cardiologist and his warm thoughtful and kind nature.
I feel very fortunate to have him as my cardiologist and always look forward to our appointments.
Dr. Maron was exceptional and a pleasure to work with. His ethic of caring is equaled by his effectiveness in educating me about my condition and the options available to me to treat it. My appointment was a learning experience that will change my life. I truly appreciated Dr. Maron's ability to translate the technical aspects of treatment into a language that I could understand. His nurturing and empathetic demeaner radiated during our video conference as his wealth of knowledge. I am truly blessed to have the opportunity to work with someone of Dr. Maron's expertise in the area of my medical circumstances. He is an excellent doctor and person!
He is good at listening to my concerns, ideas and needs and coming up with info, recommendations and ideas for me. He is patient with me as well.
Excellent
He is good doctor
Dr. Maron very thoughtful and provides details treatment plan. I feel very fortunate to be among his patients.
Dr. Maron is a thoughtful doctor who cares about his patients.
Excellent meeting and he went out of his way to see me at short notice. Very much appreciated. Impressive session.
Attentive, good bedside care, knowledgeable,
Excellent Doctor, so glad he is my Cardiologist and in charge of my care!
Appears to be a very thoughtful and intelligent human being both patient and informative. Well worth the time.
Dr. Maron is patient, informative, professional and well versed in his craft. It has been a pleasure talking with him about my health.
Very knowledgeable and thorough, clear communicator.
very thorough, engaged, asked questions
Great doctor
He’s a rock star/ guru!
Dr. Moran was professional, patient, articulate and fluid with his knowledge. It was a pleasure meeting with him.
Spectacular. Can’t thank him enough.
I feel very confident in the action plan Dr. Maron provided. I feel more hopeful after our appointment.
Thanks for the excellent, informative visit!
Truly outstanding, a consummate professional, thorough, instructive, responsive and current in the field.
He is #1 in my book. Very down to earth and I love and respect the fact that he is a "preventative" heart doctor.
I am privileged to have Dr. Maron as my cardiologists. Dr. Maron is one of the most caring, honest. and knowledgeable physician......providing the patient the fullest confidence and ease of mind.
I had a pleasant and informative conversation with Dr. Maron.
He went over my current lab reports and made excellent recommendations about where, and how I can improve my overall health, both through, exercise, diet as well as medication.
Terrific doc. Very knowledgeable.
Dr. Maron is a phenomenal physician, thoughtful and thorough. He is compassionate and extremely articulate. He is one of the best doctors I have ever had the privilege to see.
Terrific doc. Couldn’t have been better. Very grateful for the consultation.
I don’t know when Ive ever had a doctor as thorough as Dr. Maron. He is knowledgeable, warm, and an excellent communicator. I feel very fortunate to have been referred to him!!!!!
Dr. Maron is a wonderful clinician!
Very excellent experience with Dr. Ramzi Budum and Dr. David Maron. Just exceptional physicians.
Dr. Maron was very informative and had all the information at his disposal to make me comfortable. Well don.
Dr. Maron is world class - brilliant caring. Included me in decision making about care.
Dr. Maron is outstanding. I could not ask for a better cardiologist or a better coach/friend to help me with my condition. He takes a real personable interest and gives all of the time it takes to get me comfortable with any questions or concerns.
Dr. Maron is a fantastic physician. The depth of his knowledge of factors relating to heart disease and his excellent communication skills are why I fly in once a year for a visit.
Drs. Maron & Shoa were superb - they helped me find a path through my unique needs and were deeply respectful of my condition and desired approach.
Dr. Clarke was exceptional in his patience and care, I felt well cared for. Dr. Maron was friendly, patient and direct. A great team.
Dr. Maron is someone I would recommend anytime. He explained everything. In my opinion I give him 5 stars.
Both Dr. Maron and the intern (or resident) were super. The intern was actually my main access point (took hx, did initial evaluation) and Maron confirmed every thing and answered questions.
One of the best most caring doctors I have ever had (Dr. Maron).
Fine, warm doctor. I have total confidence in it's care.
Wonderful, patient, easy to talk to, would recommend to anyone with concerns.
Quite simply the best!
Excellent friendly physician who spent a lot of time counseling.
Dr. Maron is the best.
Dr. Maron is very thorough and patient, and takes the time to address all patient concerns and questions.
Outstanding meeting. Thorough, non-rushed - very comfortable discussion.
Excellent!
He's an excellent dr., gave me time, answer questions and was knowledgeable.
Superb quality time w/Dr. Maron!
I am grateful and very please to meet Dr. Maron. He is a great dr. He is very caring and listen to my concern. I am very happy that he is my dr.
Dr. Maron is a caring, curious engaging, respectful, & highly competent practitioner. I have complete faith & confidence in his medical expertise.
Dr. Maron took time to hear my issues. Didn't feel rushed at all. Had great confidence in him.
Good.
Thoroughly enjoyed my time with Dr. Maron. Very thorough and made me feel at ease right from the start.
Dr. Maron was excellent. He took the time to explain everything & made sure I understood the plan. 5 stars.
Dr. Maron was excellent in his communications and understanding of my health issues. Took a great amount of time which was appreciated.
Dr. Maron is the BEST cardiologist I have met with in many years. His knowledge about the research is an added bonus.
Dr. Maron is a rock star!
Dr. Maron was absolutely wonderful! He spent a great deal of time with me and was able to get me in the same day for a scan. This follow up treatment is excellent! I highly recommend him!
Very good experience.
Dr Maron is by far and away the very best physician one could hope for.
Dr. Maron was incredible! It was worth the wait! All excellent.
Appreciate Dr. Maron's pleasant nature.
Dr. Maron is great!!!! Kind, paient, attentive, caring, wonderful "bedside" manner
Very attentive.
Dr. Maron was very patient & kind. Took the time in explaining, did not feel rushed - Walked me out to front desk to check out.
Dr Maron spent an entire hour with us. That never happens. And I see a lot of doctors.
My experience was excellent and it surpass my expectation. If my worries are addressed even more in decision making, the experience would have been perfect.
Excellent!
Dr. Maron is one of the best! Absolutely exemplary.
Would definitely recommend this doctor, best doctors visit I ever had.
He is very very good.
Provider was very friendly & cooperative after an appointment of one week he called personally to find out - how I am feeling etc. - excellent service.
Warm caring, clearly explained new meds and alternatives.
Dr. Maron is a great doctor. I am lucky to know him.
Fantastic. As retired Stanford faculty, I was surprised & pleased by QUANTITY and quality of care.
Very good experience.
Good.
Dr. Maron is a gift - great doctor!!
My doctor was very professional.
All excellent!
My experience with Dr. Maron was the best I have had with a doctor at Stanford.
Very, very professional!
Good.
Dr. Maron was fantastic. Explained his findings and clearly had reviewed my medical history. Made me feel at ease.
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records